Date: September 17, 2026 at 1 p.m. - 2 p.m.
Location: Pacific Design Center (Green Building), 8687 Melrose Ave, West Hollywood, CA 90069
Advancing Biomarker Research and Therapeutic Development with Ultrasensitive Simoa Technology
In partnership with 
Cedars-Sinai Medical Center Proteomics and Metabolomics Core
Join researchers from Cedars-Sinai Medical Center and Quanterix on September 17, 2026, at the Pacific Design Center in West Hollywood for a seminar exploring how the Simoa® HD-X Analyzer is redefining biomarker discovery with fully automated, ultrasensitive immunoassay technology. Delivering single-digit femtogram-level detection and custom assay development capabilities, the HD-X platform empowers researchers to measure biomarkers once thought beyond reach.
This seminar will highlight how Simoa technology is advancing biomarker detection, enabling deeper biological insights, and supporting patient stratification across neurology, oncology, and cardiology research.
This seminar is hosted in partnership with the Cedars-Sinai Proteomics and Metabolomics Core which provides access to advanced immunology and biomarker technologies to support cutting‑edge translational and clinical research.
What We’ll Cover
- Simoa HD-X technology for ultrasensitive biomarker detection
- Fully automated immunoassay workflows and single-digit femtogram level detection
- Custom assay development for challenging biomarker targets
- Applications across neurology, oncology, and cardiology research
- How ultrasensitive biomarker detection can enable deeper biological insights
- Applications of Simoa technology in patient stratification
Discover how Simoa technology can help advance your biomarker research and expand what is possible with ultrasensitive detection. Reserve your spot today to take your research further.
Agenda
| Time | Topic |
|---|---|
|
1:00 p.m. |
Welcome and introductions |
|
1:05 p.m. |
Simoa technology and relevant applications Naomi Swanta, PhD, Senior Field Application Scientist, Quanterix |
|
1:30 p.m. |
Research Presentation: Applications of Simoa technology Young Lim, PhD, Assistant Professor, Cedars-Sinai, Pathology and Laboratory Medicine |
|
1:50 p.m. |
Question and answer session |
Presenters
Youngshin Lim, PhD
Assistant Professor, Cedars-Sinai Medical Center, Pathology and Laboratory Medicine
Naomi Swanta, PhD
Senior Field Application Scientist, Quanterix
Register now
Complete the form to let us know you are attending.
Learn about our instruments
Delivering ultrasensitive biomarker measurement you can count on.
Introducing the world’s most sensitive, fully automated immunoassay platform with multiplexing and custom assay capability.
Up to 1000x greater sensitivity
Up to 4 biomarkers in a single assay
Compatible with 80+ assays
Offers researchers access to ultra-sensitive biomarker detection capabilities in a compact and affordable system.
Up to 1000x greater sensitivity
Up to 4 biomarkers in a single assay
Compatible with 30+ assays
